Tag: Medicare Part D
AARP says certain drug costs could fall 50%
January 8, 2026HME News Staff
WASHINGTON – Out-of-pocket expenses for 10 high-cost prescription drugs are projected to fall by an average of more than 50% for Medicare Part D enrollees when lower prices take effect on Jan. 1, 2026, according to a new analysis released by the AARP. The analysis, conducted in December 2025, examined enrollee cost-sharing and other coverage characteristics among stand-alone Part D plans that were available in five states with high Medicare enrollment. The...
Administration rolls out Medicare drug negotiations
August 30, 2023HME News Staff
WASHINGTON – The Department of Health and Human services has announced the first 10 medicines under Medicare Part D that have been selected under the Medicare Drug Price Negotiation Program.
They are: Eliquis, Jardiance, Xarelto, Januvia, Farxiga, Entresto, Enbrel, Imbruvica, Stelara, and Fiasp and Novolog insulin products.
These drugs accounted for $50.5 billion in total Part D gross covered prescription drug costs, or about 20%, of total Part D gross covered prescription drug costs...